ResearcherUniversity of British ColumbiaActive in the last 2 years
Devika Basnagge Chithrani
Matched on ORCID iD 0000-0001-5251-1388; OpenAlex author ID A5009731325.
Their work
- Papers
- 3 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 2
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 3
- Radiosensitization by Docetaxel Prodrug-Loaded Lipid Nanoparticles in Pancreatic Cancer Xenografts. Last author DOI 10.3390/nano15191521↗
- In Vitro and In Vivo Synergetic Radiotherapy with Gold Nanoparticles and Docetaxel for Pancreatic Cancer. Last author DOI 10.3390/pharmaceutics16060713↗
- Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Treatment of Pancreatic Cancer. Last author DOI 10.3390/cancers14246137↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Abdulaziz Alhussan · 3 shared papers, 2022–2025
- Paper Radiosensitization by Docetaxel Prodrug-Loaded Lipid Nanoparticles in Pancreatic Cancer Xenografts. DOI 10.3390/nano15191521↗
- Paper In Vitro and In Vivo Synergetic Radiotherapy with Gold Nanoparticles and Docetaxel for Pancreatic Cancer. DOI 10.3390/pharmaceutics16060713↗
- Paper Lipid-Nanoparticle-Mediated Delivery of Docetaxel Prodrug for Exploiting Full Potential of Gold Nanoparticles in the Tr… DOI 10.3390/cancers14246137↗
- Sunil Krishnan Krishnan · 1 shared paper, 2022
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.